Silverback Therapeutics Stock Company Profile

Healthcare > Biotechnology

Buy SBTX

*Your capital is at risk

$6.30

+0 (+0%)

At Close: Feb 07, 2023

Information

500 Fairview Avenue North, Suite 600

Seattle WA 98109

206 456 2900

www.silverbacktx.com

Industry: Biotechnology

Sector: Healthcare

Description

Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverback Therapeutics, Inc. was incorporated in 2016 and is headquartered in Seattle, Washington.

ABOUT SILVERBACK THERAPEUTICS, INC.

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	4.43%	Jun 01
N NVRI $19.53	0.87%	May 20
RUN $12.83	15.51%	May 06
GLBE $31.61	4.05%	May 05
SAP $172.39	8.56%	May 05

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by